CVE-2023-34472

CVE-2023-34472 is a medium-severity vulnerability in Ami Megarac Sp-x with a CVSS 3.x base score of 5.7. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-93.

Key facts

Description

AMI SPx contains a vulnerability in the BMC where an Attacker may cause an improper neutralization of CRLF sequences in HTTP Headers. A successful exploit of this vulnerability may lead to a loss of integrity.

Frequently asked questions

What is CVE-2023-34472?
AMI SPx contains a vulnerability in the BMC where an Attacker may cause an improper neutralization of CRLF sequences in HTTP Headers. A successful exploit of this vulnerability may lead to a loss of integrity.
How severe is CVE-2023-34472?
CVE-2023-34472 has a CVSS 3.x base score of 5.7, rated medium severity. It is exploitable over an adjacent network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is none, integrity high, and availability none.
Is CVE-2023-34472 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (38th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-34472?
CVE-2023-34472 primarily affects Ami Megarac Sp-x. In total, 2 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2023-34472?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2023-34472 published?
CVE-2023-34472 was published on 2023-07-05 and last updated on 2026-06-17.

References

Affected products (2)

More vulnerabilities in Ami Megarac Sp-x

All CVEs affecting Ami Megarac Sp-x →

Other CWE-93 (CRLF Injection) vulnerabilities

Browse all CWE-93 (CRLF Injection) vulnerabilities →